CLINICAL_TRIALS
trial_result
· 2025-04-17
Clinical Trial Update: Clinical Study of 18F -FAPI-RGD in Renal Tumor
Summary
The clinical study evaluating the imaging tracer 18F-FAPI-RGD for renal cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sichuan Provincial People's Hospital | Conditions: Renal Tumor | Status: COMPLETED